DEFM14A: Distoken Acquisition Corporation Announces Business Combination with Youlife Group Inc.

Sentiment:

Proxy Statement/Prospectus


Distoken Acquisition Corporation aims to merge with Youlife Group Inc., valuing the latter at $700 million, pending shareholder approval at an April 30, 2025 meeting.

Summary

  • Distoken Acquisition Corporation plans a business combination with Youlife Group Inc., valuing Youlife at $700 million.
  • The merger consideration will be paid entirely in newly issued Pubco Class A and Class B Ordinary Shares, valued at $10.00 per share.
  • Distoken shareholders will vote on the proposed Business Combination Agreement at an extraordinary general meeting scheduled for April 30, 2025.
  • Upon completion, Distoken and Youlife will become wholly-owned subsidiaries of Pubco.
  • Pubco has applied to list its ADSs and warrants on Nasdaq under the symbols YOUL and YOULW, respectively.
  • If no redemptions occur, Distoken public shareholders would own approximately 1.8% of Pubco Ordinary Shares, the Sponsor would own approximately 3.5%, and Youlife Shareholders would own approximately 94.7%.
  • If maximum redemptions occur, Distoken public shareholders would own approximately 0.9% of Pubco Ordinary Shares, the Sponsor would own approximately 3.6%, and Youlife Shareholders would own approximately 95.5%.
  • Mr. Yunlei Wang, CEO and Chairman of Youlife and Pubco, will beneficially own all of the Pubco Class B Ordinary Shares, giving him approximately 78.1% to 78.2% of the voting power.
  • The Board of Directors of Distoken obtained a fairness opinion from Marshall & Stevens Transaction Advisory Services LLC, dated May 15, 2024, which provided that, as of that date and based on and subject to the assumptions, qualifications and other matters set forth therein, the consideration to be paid by Distoken in the Business Combination was fair, from a financial point of view, to Distoken.

Sentiment

Score: 7

Explanation: The document is largely factual and positive, outlining the terms of the business combination. The risks are acknowledged, but the overall tone is optimistic about the future prospects of the combined company.

Positives

  • The Business Combination Agreement has been approved by the Board of Directors of Distoken.
  • A fairness opinion from Marshall & Stevens supports the financial fairness of the transaction to Distoken.
  • The Business Combination is expected to provide Youlife with greater access to capital and an expanded range of potential investors as a public company.
  • The Business Combination is expected to enhance institutional visibility and credibility, as well as increase public market awareness of Youlife and its business model.

Negatives

  • Distoken shareholders that elect not to redeem their Public Shares will experience significant dilution as a result of the Business Combination.
  • The Sponsor and Distokens directors, officers and advisors may have interests in the Business Combination that are different from, or in addition to, those of Distokens other shareholders generally.
  • Mr. Yunlei Wang will have significant control over Pubco due to his ownership of Class B Ordinary Shares, which may prevent other shareholders from influencing significant decisions.
  • Pubco will be a controlled company and a foreign private issuer, which may result in less stringent corporate governance requirements and less protection for shareholders.

Risks

  • The Business Combination is subject to various closing conditions, and if these conditions are not satisfied or waived, the Business Combination may not be consummated.
  • Public Shareholders may vote in favor of the Business Combination and still exercise their redemption rights.
  • The Public Shareholders will experience significant dilution as a result of the Business Combination.
  • The Sponsor, Distokens directors, officers and advisors may have interests in the Business Combination that are different from, or in addition to, those of Distokens other shareholders generally.
  • Distokens officers and directors allocating their time to other businesses and potentially having conflicts of interest with Distokens business or in approving the Business Combination.
  • The ability to list Pubco securities on Nasdaq and maintain such listing following the Business Combination.
  • Geopolitical risks, including the impacts of the ongoing conflict between Russia and Ukraine, and changes in applicable laws or regulations.
  • Anticipated economic, business, and/or competitive factors.
  • Anticipations regarding the impact of any major disease or epidemic that disrupts Youlifes business.
  • Litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on Youlifes resources.
  • Exchange rate instability.
  • The possibility that expansion of Youlifes or Pubcos customer offerings or certain operations may subject it to additional legal and regulatory requirements, including tort liability.
  • Youlifes or Pubcos ability to retain and grow its customer base.
  • Youlifes or Pubcos success in finding and maintaining future strategic partnerships and inorganic opportunities.
  • The potential liquidity and trading of public securities of Pubco.
  • The ability to raise financing in the future by Pubco.
  • The ability of Youlife or Pubco to respond to general economic conditions.
  • Expansion and other plans and opportunities of Youlife or Pubco.
  • The ability of Youlife or Pubco to manage its growth effectively.
  • The ability of Youlife or Pubco to develop and protect its brand.
  • The ability of Youlife or Pubco to compete with competitors in existing and new markets and offerings.

Future Outlook

Pubco intends to take advantage of exemptions from various reporting requirements that are applicable to most other public companies, whether or not they are classified as emerging growth companies.

Industry Context

The document does not provide specific details on how this announcement relates to broader industry trends or competitors beyond stating that Youlife is a market leader in the blue-collar lifetime service industry.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorsDistoken BoardYunlei Wang, Lidong Zhu, Xiaolin Gou, Yunqiu Dai, Clement Ka Hai Hung, Huifang Cheng and Yeeli Hua ZhengUpon ClosingNew board to be appointed upon closing of the Business Combination

Related Party Transactions

  • The Sponsor has provided loans to Distoken in the aggregate amount of $1,720,000 in exchange for (i) the Working Capital Loan Note in the principal amount of up to $1,000,000 for Distokens working capital needs and (ii) the Extension Notes in the aggregate principal amounts of up to $720,000 in connection with the Extension Amendments.
  • The Sponsor is entitled to $10,000 per month for office space, administrative and support services until the completion of an initial business combination under the Administrative Services Agreement.

Stakeholder Impact

  • Distoken shareholders will have the opportunity to vote on the Business Combination Agreement.
  • Public Shareholders may redeem their Public Shares for cash if the Business Combination is consummated.
  • The Business Combination is expected to provide Youlife with greater access to capital and an expanded range of potential investors as a public company.
  • The Business Combination is expected to enhance institutional visibility and credibility, as well as increase public market awareness of Youlife and its business model.

Next Steps

  • Distoken shareholders will vote on the Business Combination Agreement at the Extraordinary General Meeting on April 30, 2025.
  • If approved, the Business Combination will be consummated as soon as practicable following the Extraordinary General Meeting.

Key Dates

DateDescription
May 17, 2024Date of the Business Combination Agreement.
November 13, 2024Date of the First Amendment to the Business Combination Agreement.
January 17, 2025Date of the Second Amendment to the Business Combination Agreement.
March 27, 2025Record date for the Extraordinary General Meeting.
April 3, 2025Date this proxy statement/prospectus is first being mailed to Distoken shareholders.
April 28, 2025Deadline for Public Shareholders to submit written request to redeem Public Shares for cash.
April 30, 2025Date of the Extraordinary General Meeting.

Keywords

Business Combination, Youlife Group, Distoken Acquisition Corporation, Merger, SPAC, Pubco, Acquisition

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.